Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00RLE
|
||||
| Former ID |
DNC013017
|
||||
| Drug Name |
4-(4-chlorobenzyl)-2-methylphthalazin-1(2H)-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528062] | ||
| Formula |
C16H13ClN2O
|
||||
| Canonical SMILES |
CN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=C(C=C3)Cl
|
||||
| InChI |
1S/C16H13ClN2O/c1-19-16(20)14-5-3-2-4-13(14)15(18-19)10-11-6-8-12(17)9-7-11/h2-9H,10H2,1H3
|
||||
| InChIKey |
QZOXWSKLFOUEKD-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-1A adrenergic receptor | Target Info | Inhibitor | [528062] | |
| Alpha-1D adrenergic receptor | Target Info | Inhibitor | [528062] | ||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
| References | |||||